Earnings · China A-shares
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD Class A (600566) earnings
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD Class A published its Q3 report on 2026-10-29: net profit +3.77% year on year, +8.19% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +6.77% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- +3.77%
- Excl. one-offs YoY
- +8.19%
- Net profit QoQ
- -27.93%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +2.64% | — |
| 3 days | +6.77% | — |
| 7 days | +9.38% | — |
| 14 days | +17.49% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 4 of 6 reports (average +1.69%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥1.06B | +3.77% | +8.19% | -7.50% | 1.15 | 7.36% | +6.77% | — | — |
| 2026 interim report | 2026-08-29 | ¥784.23M | +8.26% | -3.90% | -15.29% | 0.85 | 5.33% | -0.12% | +7.11% | +16.44% |
| 2026 Q1 report | 2026-04-24 | ¥400.14M | -9.13% | -8.87% | -20.84% | 0.44 | 2.70% | +6.24% | +9.26% | +8.84% |
| 2025 annual report | 2026-04-24 | ¥1.78B | -29.77% | -31.10% | -22.43% | 1.93 | 12.28% | +6.24% | +9.26% | +8.84% |
| 2025 Q3 report | 2025-10-28 | ¥1.02B | -46.27% | -49.43% | -32.27% | 1.11 | 7.12% | +0.20% | +10.16% | +13.53% |
| 2025 interim report | 2025-08-23 | ¥724.36M | -45.87% | -47.43% | -31.87% | 0.78 | 4.91% | -5.67% | -9.81% | -14.68% |
| 2025 Q1 report | 2025-04-26 | ¥440.34M | -47.91% | -46.01% | -36.51% | 0.48 | 2.95% | +2.74% | +9.93% | +6.68% |
| 2024 annual report | 2025-04-26 | ¥2.53B | -10.32% | -15.84% | -16.96% | 2.76 | 18.18% | +2.74% | +9.93% | +6.68% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.